tradingkey.logo
tradingkey.logo
검색

Simulations Plus Inc

SLP
관심 목록에 추가
18.390USD
+0.040+0.22%
종가 07/02, 13:00ET시세는 15분 지연됩니다
370.50M시가총액
손실P/E TTM

Simulations Plus Inc

18.390
+0.040+0.22%

자세한 내용은 Simulations Plus Inc 회사

Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.

Simulations Plus Inc 정보

종목 코드 SLP
회사 이름Simulations Plus Inc
상장일Jun 18, 1997
CEOO'Connor (Shawn M)
직원 수212
유형Ordinary Share
회계 연도 종료Jun 18
주소800 Park Offices Drive, Suite 401
도시RESEARCH TRIANGLE PARK
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호27709
전화16617237723
웹사이트https://www.simulations-plus.com/
종목 코드 SLP
상장일Jun 18, 1997
CEOO'Connor (Shawn M)

Simulations Plus Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.25M
-0.46%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
17.17K
+12.33%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
14.59K
+14.51%
Ms. Jenna Rouse
Ms. Jenna Rouse
Global Head - Clinical Operations
Global Head - Clinical Operations
--
--
Mr. Murry Alper
Mr. Murry Alper
Global Head - Medical Communications
Global Head - Medical Communications
--
--
Ms. Lisa Fortuna
Ms. Lisa Fortuna
Investor Relations
Investor Relations
--
--
Mr. Josh Fohey
Mr. Josh Fohey
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Erik Guffrey
Mr. Erik Guffrey
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
--
--
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.25M
-0.46%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
17.17K
+12.33%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
14.59K
+14.51%
Ms. Jenna Rouse
Ms. Jenna Rouse
Global Head - Clinical Operations
Global Head - Clinical Operations
--
--
Mr. Murry Alper
Mr. Murry Alper
Global Head - Medical Communications
Global Head - Medical Communications
--
--

자주 묻는 질문

Simulations Plus Inc의 상위 5대 주주는 누구인가요?

Simulations Plus Inc의 상위 5대 주주는 다음과 같습니다: Dr. Hon. Walter S. Woltosz

Simulations Plus Inc(SLP)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Simulations Plus Inc의 주식을 보유한 기관은 총 432곳이며, 이들이 보유한 주식의 총 가치는 약 17.68M로 전체 발행 주식의 87.48%를 차지합니다. 이는 2025Q4 대비 -4627215.00 증가한 수치입니다.

Simulations Plus Inc의 최대 수익원은 무엇인가요?

2026Q1 기준, Simulations Plus Inc의 Consulting services 부문이 가장 높은 매출을 기록했으며, 금액은 9.54M로 전체 매출의 51.78%를 차지했습니다.